Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype
Date
2018Journal
Blood advancesPublisher
American Society of HematologyType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049422952&doi=10.1182%2fbloodadvances.2017012682&partnerID=40&md5=59d0d384def606389b8e389f1f8c38e4; http://hdl.handle.net/10713/9660ae974a485f413a2113503eed53cd6c53
10.1182/bloodadvances.2017012682
Scopus Count
Collections
Related articles
- Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
- Authors: Manabe A
- Issue date: 2016 Apr
- I walk the line: how to tell MDS from other bone marrow failure conditions.
- Authors: Gondek LP, DeZern AE
- Issue date: 2014 Dec
- Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
- Authors: Dalle JH, Peffault de Latour R
- Issue date: 2016 Apr
- Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.
- Authors: Scott BL, Storer BE, Greene JE, Hackman RC, Appelbaum FR, Deeg HJ
- Issue date: 2007 Mar
- Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system.
- Authors: Tong WG, Quintás-Cardama A, Kadia T, Borthakur G, Jabbour E, Ravandi F, Faderl S, Wierda W, Pierce S, Shan J, Bueso-Ramos C, Kantarjian H, Garcia-Manero G
- Issue date: 2012 Sep 15